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The prevalence of the recently identiﬁ  ed  astrovirus 
MLB1 in a cohort of children with diarrhea in St. Louis, Mis-
souri, USA, was deﬁ  ned by reverse transcription–PCR. Of 
254 stool specimens collected in 2008, 4 were positive for 
astrovirus MLB1. These results show that astrovirus MLB1 
is circulating in North America.
A
stroviruses infect a variety of hosts, including humans, 
turkeys, chicken, cattle, sheep, dogs, cats, deer, ducks, 
and bats (1,2). The 8 known human serotypes are geneti-
cally closely related. Astroviruses typically cause diarrhea 
in their hosts; in humans, symptoms usually last 2–4 days 
(3). Children <2 years of age, elderly persons, or otherwise 
immunocompromised persons are most commonly affected 
(3). Epidemiologic studies suggest human astroviruses 1–8 
are responsible for up to ≈10% of cases of acute, nonbacte-
rial diarrhea in children (4–8).
Recently, a highly divergent astrovirus, referred to as 
astrovirus MLB1 (AstV-MLB1), was identiﬁ  ed in the stool 
of a 3-year-old boy in Australia (9). The entire genome of 
this novel virus was subsequently sequenced and character-
ized (10). No published reports have described AstV-MLB1 
outside of the index case. In this study, we determined the 
prevalence of this novel virus by reverse transcription–
PCR (RT-PCR) screening of stool samples collected at the 
St. Louis Children’s Hospital in St. Louis, Missouri.
The Study
Pediatric stool specimens sent for bacterial culture to 
the clinical microbiology laboratory at the St. Louis Chil-
dren’s Hospital were analyzed for AstV-MLB1. The Hu-
man Research Protection Ofﬁ  ce of Washington University 
in St. Louis approved this study. Samples were collected 
during January through May 2008. Stools were diluted in 
phosphate-buffered saline at a 1:6 ratio (wt/vol), and total 
nucleic acid was extracted from 200 μL of each stool sus-
pension by the MagNAPure LC Automated Nucleic Acid 
Extraction System (Roche, Indianapolis, IN, USA).
Previously described astrovirus primers Mon269 and 
Mon270 (11) frequently have been used for detecting hu-
man astrovirus serotypes 1–8 in clinical stool specimens. 
However, the extensive divergence of AstV-MLB1 to the 
known human astroviruses rendered these primers unable 
to amplify AstV-MLB1 (data not shown). Because AstV-
MLB1 might represent a new grouping of astroviruses that 
could include multiple subtypes, we designed primers to 
conserved regions of the AstV-MLB1 genome to maximize 
the likelihood of detecting any AstV-MLB1 variant viruses 
or even other novel astroviruses.
We identiﬁ  ed conserved regions by using multiple se-
quence alignments of AstV-MLB1 amino acid sequences to 
all fully sequenced astrovirus genomes (Figure 1, panels A 
and B). The corresponding nucleotide sequences for these re-
gions were then aligned to deﬁ  ne the most highly conserved 
regions (Figure 1, panels C and D). Two regions within open 
reading frame (ORF) 1b were identiﬁ  ed that yielded prim-
ers SF0073 (5′-GATTGGACTCGATTTGATGG-3′) and 
SF0076 (5′-CTGGCTTAACCCACATTCC-3′), which are 
predicted to generate an ≈409-bp product. Control experi-
ments validated this primer pair could detect AstV-MLB1, 
as well as human astrovirus 1 (online Appendix Figure, 
available from www.cdc.gov/EID/content/15/3/441-appF.
htm). Given that some of the canonical human astroviruses 
are identical in the primer binding sites, these data suggest 
that at least some of the canonical human astroviruses can 
be detected by the primer pair SF0073/SF0076. In theory, 
under appropriate experimental conditions, these primers 
also may be able to detect all other known human and ani-
mal astroviruses, although that remains to be experimen-
tally tested. These primers were used with the QIAGEN 
One-Step RT-PCR Kit (QIAGEN, Valencia, CA, USA) by 
using the following cycling conditions: 30 min RT step, 
94ºC for 10 min, followed by 40 cycles of 94ºC for 30 s, 
52ºC for 30 s, and 72ºC for 50 s.
Samples that tested positive with primers SF0073 
and SF0076 were then tested in a second round of screen-
ing with 2 different primer sets in parallel to determine 
whether the samples contained canonical human astrovi-
rus serotypes 1–8 or AstV-MLB1. The previously report-
ed Mon269 (5′-CAACTCAGGAAACAGGGTGT-3′) and 
Mon270 (5′-TCAGATGCATTGTCATTGGT-3′) primers, 
which generate a 449-bp amplicon, were used to detect ca-
nonical human astroviruses (11). Another set of primers, 
SF0053 (5′-CTGTAGCTCGTGTTAGTCTTAACA-3′) 
and SF0061 (5′-GTTCATTGGCACCATCAGAAC-3′), 
was designed to exclusively detect AstV-MLB1 and pro-
duce a 402-bp PCR product. These primers target a re-
gion of the capsid gene. The second round of screening 
with both sets of primer pairs was performed as described 
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Of 254 stool specimens screened, 9 (3.5%) tested posi-
tive in the initial round of screening that used the newly 
designed pan-astrovirus primers, SF0073 and SF0076. 
Secondary screening showed that 5 (2% of all samples) 
were canonical human astroviruses. This probably under-
estimates the prevalence of the astrovirus serotype 1–8 in 
the cohort because the initial screening primers were bi-
ased toward detection of AstV-MLB1. The remaining 4 
(1.6% of all samples) were positive for AstV-MLB1 us-
ing primers SF0053 and SF0061. For each of the 4 sam-
ples positive for AstV-MLB1, 2 additional fragments 
were generated by RT-PCR for phylogenetic analysis. 
A 1,228-bp fragment of ORF1a, which encodes the ser-
ine protease, and a 920-bp fragment of ORF2, which 
encodes the capsid proteins, were ampliﬁ  ed using AstV-
MLB1–speciﬁ  c primers from each of the 4 samples des-
ignated WD0016, WD0055, WD0104, and WD0227. 
The primers used for the ORF1a fragment are SF0080 
(5′-AAGGATAGTGCTGGTAAAGTAGTTCAGA-3′) 
and SF0094 (5′-CAAGAGCCTTATCAACAACGTA-3′) 
and the primers used for the ORF2 fragment are SF0064 
(5′-GTAAGCATGGTTCTTGTGGAC-3′) and SF0098 
(5′-TGCATACATTTATGCTGGAAGA-3′). The ORF1a 
fragments (GenBank accession nos. FJ227120–FJ227123) 
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Figure 1. Astrovirus open reading frame (ORF) 1b alignments for design of pan-astrovirus primers. Astrovirus RNA polymerase sequences 
(ORF1b) were aligned at the amino acid level to deﬁ  ne the conserved regions used for the design of primers SF0073 (A) and SF0076 (B). 
The numbers to the right of the sequences indicate the position of the last amino acid within each ORF1b sequence. Red boxes represent 
the speciﬁ  c regions that were reverse translated into the corresponding nucleic acid sequences used for the design of SF0073 (C) and 
SF0076 (D). Red sequences shown in the nucleotide alignments are the actual primer sequences. Asterisks indicate nucleotide identity.
Figure 2. Phylogenetic analysis of 
astrovirus MLB1 (AstV-MLB1) isolates. A 
region of the serine protease (A) and the 
capsid (B) of each virus detected by the 
AstV-MLB1–speciﬁ  c primers was ampliﬁ  ed 
and sequenced. Multiple sequence 
alignments were then generated with 
these sequences and the corresponding 
regions of known astroviruses using 
ClustalX (www.clustal.org). PAUP* 
(Sinauer Associates, Sunderland, MA, 
USA) was used to generate phylogenetic 
trees; bootstrap values (>700) from 1,000 
replicates are shown. The previously 
identiﬁ   ed AstV-MLB1 isolate (9,10) and 
the isolates from this study are shown in 
boldface. Scale bars indicate number of 
amino acid substitutions per site.Astrovirus MLB1 in Stool Samples from Children
from these samples all shared ≈92% nt identity to the refer-
ence astrovirus MLB1 sequence (GenBank accession no.: 
FJ222451) and 99% aa identity, indicating that most muta-
tions were synonymous. The ORF2 fragments (GenBank 
accession nos. FJ227124–FJ227127) shared ≈91%–92% nt 
identity and 95%–96% aa identity to the reference astro-
virus MLB1 sequence. The 4 positive St. Louis samples 
shared ≈99% nt identity to each other. The ORF1a and 
ORF2 sequences were aligned to other astroviruses for 
which full genome sequences were available using Clust-
alX version 1.83 (www.clustal.org); maximum-parsimony 
trees were generated using PAUP with 1,000 bootstrap rep-
licates (12) (Figure 2). The entire genome of one of the 
isolates, WD0016 (GenBank accession no. FJ402983), 
was sequenced and had 92.6% identity overall to that of 
AstV-MLB1 on the basis of a pairwise nucleotide align-
ment (Table 1).
Patients with AstV-MLB1–positive stools ranged in age 
from ≈4 months to 4 years (Table 2). All patients had symp-
toms of diarrhea at stool collection, except the patient with 
isolate WD0016, who reported having diarrhea 2 days before 
stool collection. All specimens were tested for Escherichia 
coli, Campylobacter spp., Yersinia spp., Shigella spp., and 
Salmonella spp. by standard bacterial culture. The WD0227 
sample tested positive for E. coli O157:H7; the other sam-
ples were negative for all bacterial cultures. A pan-viral mi-
croarray, the ViroChip (GEO platform GPL 3429; National 
Center for Biotechnology Information, Bethesda, MD, USA) 
(13), was used to examine whether other viruses were pres-
ent in the stool of 3 (WD0055, WD0104, and WD0227) of 
the 4 AstV-MLB1–positive samples for which enough ma-
terial remained for analysis. WD0055 and WD0104 were 
negative by array, but WD0227 was positive for rotavirus as 
determined by the ViroChip.
Conclusions
The newly identiﬁ  ed AstV-MLB1 virus was discov-
ered in a stool specimen collected in Melbourne, Victoria, 
Australia, in 1999. In this study, we describe the detec-
tion of AstV-MLB1 in a cohort from St. Louis collected in 
2008. This observation provides evidence of AstV-MLB1 
outside Australia and suggests that AstV-MLB1 is likely to 
be globally widespread. In addition, these data demonstrate 
that AstV-MLB1 is circulating in the human population. 
The sequence divergence of ≈8% at the nucleotide level 
between the reference AstV-MLB1 genome and the viruses 
detected in this study suggests substantial sequence hetero-
geneity within the AstV-MLB1 group of viruses. Multiple 
serotypes or subtypes of AstV-MLB1 might exist, as with 
the canonical human astroviruses. More extensive screening 
of stool samples with PCR primers targeted toward detec-
tion of AstV-MLB1, such as those described here, may pro-
vide insight into the true diversity and prevalence of AstV-
MLB1–like viruses. Finally, a critical direction for future 
investigation is determining whether AstV-MLB1, like the 
canonical astrovirus serotypes 1–8, is a causal agent of hu-
man diarrhea, and if so, assessing the extent and severity of 
disease associated with this virus. Further epidemiologic 
studies, including both case–control prevalence studies and 
seroprevalence assays, and efforts to fulﬁ  ll Koch’s postu-
lates should be pursued.
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Table 1. Similarity of fully sequenced WD0016 genome to AstV-
MLB1*
Nucleotide identity with AstV-MLB1, % 
Genome
ORF1a  
(serine protease)
ORF1b  
(RNA polymerase)
ORF2 
(capsid)
WD0016 92.6 93.9 91.9
*AstV-MLB1, astrovirus MLB1; ORF, open reading frame. 
Table 2. Clinical and demographic characteristics of patients with stool samples positive for astrovirus MLB1
Sample
Characteristic WD0016 WD0055 WD0104 WD0227
Age, m 15 17 4 43
Sex F F M M
Diarrhea No* Yes Yes Yes
Other symptoms Abdominal pain Vomiting, fever Fever, seizures, 
respiratory distress
Fever
Hospitalization Yes No Yes Yes
Bacterial cultures† Negative Negative Negative Positive for E. coli
O157:H7
*Patient had diarrhea 2 days before stool collection but not at collection. 
†Tests were conducted for Escherichia coli, Campylobacter spp., Shigella spp., Salmonella spp., and Yersinia spp. References
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